Top Markets
#1 Orochi Network Orochi Network +71.79%
#2 Bitway Bitway +26.98%
#3 Audiera Audiera +24.63%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.60%
#5 Pharos Pharos +15.97%
#6 SOON SOON +15.75%
#7 Cheems Token Cheems Token +14.21%
#8 Taiko Taiko +13.85%
#9 Manadia Manadia +13.47%
#10 ROLL ROLL +13.27%
Coin of the day
Orochi Network Orochi Network
Settings
Language
ENGLISH
Currency
USD
Theme
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Rank in Stocks #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Share Price
$50.95
Market Cap
$226.41B
Change (1 day)
2.58%
Change (1 year)
-26.16%
Country
DK
Trade Novo Nordisk A/S (NVO)

Category

Healthcare
Operating Margin for Novo Nordisk A/S (NVO)
Operating Margin as of July 2026 TTM: 45.30%
According to Novo Nordisk A/S latest financial reports and stock price the company's current Operating Margin (TTM) is 45.30%. At the end of 2024 the company had an Operating Margin of 44.19%.
Operating Margin history for Novo Nordisk A/S from 2000 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
2026 (TTM) 45.30% 9.42%
2025 41.40% -6.31%
2024 44.19% 0.07%
2023 44.16% 4.45%
2022 42.28% 1.51%
2021 41.65% -2.32%
2020 42.64% -0.86%
2019 43.01% 1.80%
2018 42.25% -3.63%
2017 43.84% 1.18%
2016 43.33% -5.41%
2015 45.81% 17.95%
2014 38.84% 3.08%
2013 37.68% -0.24%
2012 37.77% 12.01%
2011 33.72% 8.49%
2010 31.08% 6.29%
2009 29.24% 7.66%
2008 27.16% 27.03%
2007 21.38% -9.14%
2006 23.53% -1.75%
2005 23.95% -0.42%
2004 24.05% -0.04%
2003 24.06% 1.31%
2002 23.75% 0.64%
2001 23.60% 15.74%
2000 20.39% 0.00%
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.97% -99.14%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
24.32% -99.46%
US
UCB SA UCB SA
UCB SA
UCB.BR
25.32% -99.44%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
25.64% -99.43%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
17.54% -99.61%
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.